Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6YNB6

Entry ID Method Resolution Chain Position Source
AF-Q6YNB6-F1 Predicted AlphaFoldDB

No variants for Q6YNB6

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6YNB6

No associated diseases with Q6YNB6

4 regional properties for Q6YNB6

Type Name Position InterPro Accession
domain Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) 243 - 421 IPR002314
domain Aminoacyl-tRNA synthetase, class II 199 - 431 IPR006195
domain Serine-tRNA synthetase, type1, N-terminal 1 - 109 IPR015866
domain Serine-tRNA ligase catalytic core domain 122 - 438 IPR033729

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
receptor complex Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

2 GO annotations of molecular function

Name Definition
follicle-stimulating hormone receptor activity Combining with follicle-stimulating hormone to initiate a change in cell activity.
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

6 GO annotations of biological process

Name Definition
cellular response to follicle-stimulating hormone stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
follicle-stimulating hormone signaling pathway A G protein-coupled receptor signaling pathway initiated by follicle-stimulating hormone binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process.
G protein-coupled receptor signaling pathway The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane.
positive regulation of ERK1 and ERK2 cascade Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
positive regulation of phosphatidylinositol 3-kinase signaling Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
regulation of protein kinase A signaling Any process that modulates the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAFLWISFLV FLGSGSGCHH RICHCSDRVF ICQESKVTEI PSDIPRNTVE MRFVLTKLQV
70 80 90 100 110 120
IPRGAFSGFR DLEKIEISQN DALEVIEADV FSNLPKLHEI RIEKANNLVL IDPEAFWNLP
130 140 150 160 170 180
NLRYLLISNT GIKHLPAVYK IQSHQKVLLD IQDNINIRTI ERNSFAGLSS ESEILWLNKN
190 200 210 220 230 240
GIQEIQNQAF NGTQLDELNL SDNINLEDLP NGIFQGANGP VILDISRTRI HSLPSDGLKN
250 260 270 280 290 300
LKKLKARSAY NFKTLPNLDK FAELVEANLT YPSHCCAFAN WRRQAFELHP ICNKSFVRQD
310 320 330 340 350 360
SDDLAMDWGH RRRSVEEEYV SNLDKGFDIT DTELDYDLCN EVVDVACSPK PDAFNPCEDI
370 380 390 400 410 420
MGYNFLRVLI WFISILSITG NIVVLVILIT SQYKLTVPRF LMCNLAFADL CIGIYLLLIA
430 440 450 460 470 480
SVDIHTKSQY HNYAIDWQTG AGCDAAGFFT VFASELSVYT LTAITLERWH TITYAMQLDR
490 500 510 520 530 540
KVRLRHAASI MLIGWIFAFS VALLPIFGVS SYMKVSICLP MDIDSPLSQF YVISLLVLNV
550 560 570 580 590 600
LASVIICTCY THIYFTVRNP NIISSTSDAK IAKRMAMLIF TDFLCMAPIS FFAISASVKM
610 620 630 640 650 660
PLITVSKSKI LLVLFYPINS CANPFLYAVF TKTFRRDFFI LLSKFGCCEM QAQIYRTETS
670 680 690
STVHSSHPRN GQCPLMAKSN SGAVYKLVPL NHLS